06-17-2017, 01:08 AM
(This post was last modified: 06-17-2017, 07:06 AM by CameronWoof. Edited 2 times in total.)
THE PROBLEM
Salbutamol is considered the baseline chemical for treating OXY damage, but its synthesis procedure is quite complex, requiring phenol (which itself requires oil), and the creation of salicylic acid to complete. Perfluorodecalin, on the other hand, requires only oil and chemicals from the dispensers to create, and is a far-and-away more effective treatment option besides. While perfluorodecalin does max out LOSEBREATH and prohibit the patient from speaking, it also stops the accrual of OXY damage from LOSEBREATH, making it both a fantastic emergency medicine and a spacewalking chem.
THE STATS
Salbutamol
-6 OXY (per tick)
-4 LOSEBREATH
No addiction chance
Safe to use in most situations
Complicated synthesis makes it difficult for beginner chemists
Perfluorodecalin
-25 OXY (per tick)
Halts the accrual of OXY damage
Removes the need for oxygen
Easy synthesis
Addictive
Patient can't speak
PROPOSED CHANGES
Perfluorodecalin's unique interaction with LOSEBREATH makes it an incredibly powerful emergency medicine, while its non-overdose-based addiction chance and removal of the patient's ability to speak are drawbacks that are more commonly found in lower-tier medicines.
I'd like for perfluorodecalin to be a more niche chem, used mainly for quick and dirty spacewalking with some drawbacks, or as a silencing poison for traitors. I'd also like salbutamol to be elevated to the place of apex anti-OXY chem more in line with its complex synthesis procedure.
I'd like to also introduce a new baseline chem, camphor, as a topically-applied anti-OXY treatment that uses salbutamol's current stats.
Camphor
-6 OXY (per tick)
-4 LOSEBREATH
Easy synthesis
Salbutamol
-25 OXY (per tick)
-4 LOSEBREATH
Overdose (25): Stuttering, dizziness, jitteriness, random stuns and confused movement. 8% chance of +1/+2 TOX.
Perfluorodecalin
-4 OXY (per tick)
Halts the accrual of OXY damage
Removes the need for oxygen
Easy synthesis
Patient can't speak
With this model, perfluorodecalin is less attractive as a medicine due to its lower anti-OXY power, and is relegated to a niche spacewalking chem that is no longer addictive. Salbutamol is much more effective, and its -25 OXY will likely outheal any mounting OXY damage the patient is suffering. Camphor takes salbutamol's place in emergency kits and vendors as the baseline anti-OXY chem, and its easy synthesis is good for learning chemists.
Wikipedia states that camphor looks like "white, translucent crystals" if that information helps.
Salbutamol is considered the baseline chemical for treating OXY damage, but its synthesis procedure is quite complex, requiring phenol (which itself requires oil), and the creation of salicylic acid to complete. Perfluorodecalin, on the other hand, requires only oil and chemicals from the dispensers to create, and is a far-and-away more effective treatment option besides. While perfluorodecalin does max out LOSEBREATH and prohibit the patient from speaking, it also stops the accrual of OXY damage from LOSEBREATH, making it both a fantastic emergency medicine and a spacewalking chem.
THE STATS
Salbutamol
-6 OXY (per tick)
-4 LOSEBREATH
No addiction chance
Safe to use in most situations
Complicated synthesis makes it difficult for beginner chemists
Perfluorodecalin
-25 OXY (per tick)
Halts the accrual of OXY damage
Removes the need for oxygen
Easy synthesis
Addictive
Patient can't speak
PROPOSED CHANGES
Perfluorodecalin's unique interaction with LOSEBREATH makes it an incredibly powerful emergency medicine, while its non-overdose-based addiction chance and removal of the patient's ability to speak are drawbacks that are more commonly found in lower-tier medicines.
I'd like for perfluorodecalin to be a more niche chem, used mainly for quick and dirty spacewalking with some drawbacks, or as a silencing poison for traitors. I'd also like salbutamol to be elevated to the place of apex anti-OXY chem more in line with its complex synthesis procedure.
I'd like to also introduce a new baseline chem, camphor, as a topically-applied anti-OXY treatment that uses salbutamol's current stats.
Camphor
-6 OXY (per tick)
-4 LOSEBREATH
Easy synthesis
Salbutamol
-25 OXY (per tick)
-4 LOSEBREATH
Overdose (25): Stuttering, dizziness, jitteriness, random stuns and confused movement. 8% chance of +1/+2 TOX.
Perfluorodecalin
-4 OXY (per tick)
Halts the accrual of OXY damage
Removes the need for oxygen
Easy synthesis
Patient can't speak
With this model, perfluorodecalin is less attractive as a medicine due to its lower anti-OXY power, and is relegated to a niche spacewalking chem that is no longer addictive. Salbutamol is much more effective, and its -25 OXY will likely outheal any mounting OXY damage the patient is suffering. Camphor takes salbutamol's place in emergency kits and vendors as the baseline anti-OXY chem, and its easy synthesis is good for learning chemists.
Wikipedia states that camphor looks like "white, translucent crystals" if that information helps.